NRX Pharmaceuticals Inc (NRXP)
2.99
-0.05
(-1.64%)
USD |
NASDAQ |
Apr 22, 16:00
2.92
-0.07
(-2.34%)
After-Hours: 20:00
NRX Pharmaceuticals Cash from Investing (TTM): -0.003M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.003M |
| September 30, 2023 | -0.003M |
| June 30, 2023 | -0.006M |
| March 31, 2023 | -0.011M |
| December 31, 2022 | -0.01M |
| Date | Value |
|---|---|
| September 30, 2022 | -0.011M |
| June 30, 2022 | -0.01M |
| March 31, 2022 | -0.01M |
| December 31, 2021 | -0.007M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.011M
Minimum
Sep 2022
-0.003M
Maximum
Sep 2023
-0.0079M
Average
-0.01M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| Achieve Life Sciences Inc | -- |
| Dare Bioscience Inc | -0.6294M |
| Zevra Therapeutics Inc | -17.39M |
| Kodiak Sciences Inc | 249.23M |
| INmune Bio Inc | -- |